Laura K. Richman - Concepedia

Author

Laura K. Richman

Also Known As

L K Richman, L Richman, L. K. Richman, L. Richman, L.K. Richman, LAURA K. RICHMAN, Larry Richman, Laura K Richman, Laura K. Richman, Laura RICHMAN

142

Publications

4.9K

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University National Zoological Park University of Pennsylvania Smithsonian Institution Brigham and Women's Hospital

About

Laura K. Richman is an author at Johns Hopkins University specializing in medicine, pathology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	19	1.3K
2	Health Sciences	2	2	39
3	Allergy	2	2	21
4	Education	1	1	11
5	Social Sciences	1	1	101

Laura K. Richman

Publications

4.7K

Citations

H-Index

Page 1

	Year	Citations
Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN Christian Hinderer, Nathan Katz, Elizabeth L. Buza, Human Gene Therapy	2018	757
Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway Brandon W. Higgs, Zheng Liu, Barbara White, Annals of the Rheumatic Diseases	2011	399
Type I Interferon: Potential Therapeutic Target for Psoriasis? Yihong Yao, Laura K. Richman, Chris Morehouse, PLoS ONE	2008	305
Neutralization of interferon‐α/β–inducible genes and downstream effect in a phase I trial of an anti–interferon‐α monoclonal antibody in systemic lupus erythematosus Yihong Yao, Laura K. Richman, Brandon W. Higgs, Arthritis & Rheumatism	2009	279
Adeno-Associated Virus-Induced Dorsal Root Ganglion Pathology Juliette Hordeaux, Elizabeth L. Buza, Cecilia Dyer, Human Gene Therapy	2020	236
Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study D. J. Wallace, M. Pétri, Kyriakos A. Kirou, Annals of the Rheumatic Diseases	2011	226
Novel Endotheliotropic Herpesviruses Fatal for Asian and African Elephants Laura K. Richman, Richard J. Montali, Richard L. Garber, Science Zoonotic DiseasePathogenesisViral PathogenesisVeterinary SciencePathology	1999	214
A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients Brandon W. Higgs, Wei Zhu, Chris Morehouse, Annals of the Rheumatic Diseases	2013	162
MiR-125a targets effector programs to stabilize Treg-mediated immune homeostasis Wen Pan, Shu Zhu, Dai Dai, Nature Communications	2015	144
Inhibition of Myogenic MicroRNAs 1, 133, and 206 by Inflammatory Cytokines Links Inflammation and Muscle Degeneration in Adult Inflammatory Myopathies Robert W. Georgantas, Katie Streicher, Steven A. Greenberg, Arthritis & Rheumatology	2013	137

Page 1